We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention and Control of Healthcare-Associated Infections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00917319
Recruitment Status : Unknown
Verified June 2009 by Mahidol University.
Recruitment status was:  Active, not recruiting
First Posted : June 10, 2009
Last Update Posted : June 17, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
Bundling infection control interventions should decrease incidence of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand

Condition or disease Intervention/treatment
Nosocomial Infection Other: Bundling Infection Control Interventions

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 2000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Randomized Controlled Study on Effectiveness of Implementing Bundling Infection Control Interventions for Prevention and Control of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand
Study Start Date : January 2009
Estimated Primary Completion Date : July 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Infection control measure
Bundling Infection Control Interventions
Other: Bundling Infection Control Interventions
identify risk factors for developing HAIs, receive general infection control measures as well as infection control measures appropriate for the identified risk factor (s)


Outcome Measures

Primary Outcome Measures :
  1. Incidence of healthcare-associated infection [ Time Frame: 7 months ]

Secondary Outcome Measures :
  1. Incidence of hospital-acquired pneumonia and catheter-associated UTI [ Time Frame: 7 months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patients hospitalized to general medical wards

Exclusion Criteria:

  • The patients hospitalized less than 48 hours
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00917319


Locations
Thailand
Department of Medicine, Faculty of Medicine Siriraj Hospital
Bangkoknoi,, Bangkok, Thailand, 10700
Sponsors and Collaborators
Mahidol University
Investigators
Principal Investigator: Visanu Thamlikitkul, MD Siriraj Hospital
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Visanu Thamlikitkul, Siriraj Hospital
ClinicalTrials.gov Identifier: NCT00917319     History of Changes
Other Study ID Numbers: Siriraj CEU 52-001
Siriraj Hospital
First Posted: June 10, 2009    Key Record Dates
Last Update Posted: June 17, 2009
Last Verified: June 2009

Additional relevant MeSH terms:
Infection
Communicable Diseases
Cross Infection
Iatrogenic Disease
Disease Attributes
Pathologic Processes